National institute of biomedical imaging and bioengineering (nibib) innovation funnel coordination center for radx innovation funnel for covid-19
Ended Awarded Last action
- Contract number
- 75N92022F00004
- Awardee
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $8,878,381
Award facts
- Opportunity
-
- 75N92022R0144 Solicitation number
- Contract value 100% obligated
- $8,878,380.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Biomedical Imaging and Bioenginering National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541614 Process, Physical Distribution, and Logistics Consulting Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02114, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Funding Only Action | $6,200,473 | |
| Other Administrative Action | $0 | |
| Original award | $2,677,908 |
About this award
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $8,878,380.66 Firm Fixed Price delivery order contract to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to establish an NIBIB Innovation Funnel Coordination Center for the RadX Innovation Funnel for COVID-19. This contract supports research, clinical, and technical services related to the development of medical countermeasures against COVID-19. MGH is a 999-bed medical center and academic research institution that frequently partners with the National Institutes of Health (NIH) and other federal agencies on biomedical research projects. The contract has an ultimate completion date of September 22, 2026 and is not associated with a set-aside designation.
Quick answers
Who was awarded contract 75N92022F00004?
75N92022F00004 was awarded to The General Hospital Corporation by National Heart Lung and Blood Institute (National Institutes of Health) on September 21, 2022.
How much is contract 75N92022F00004 worth?
The government has obligated $8,878,381 on 75N92022F00004.
Which agency awarded contract 75N92022F00004?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92022F00004, with funding from National Institute of Biomedical Imaging and Bioenginering (National Institutes of Health).
Is contract 75N92022F00004 an order under another contract?
Yes. 75N92022F00004 is a delivery order under 75N92022D00014, an indefinite delivery contract.
Was contract 75N92022F00004 competed?
The extent of competition for 75N92022F00004 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award